-
Fund Dashboard
- Holdings
Franklin Genomic Advancements ETF
Fund Profile
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
NTRA Natera, Inc. | 753.03 k | 4.76 k shares | 5.78 | Common equity | Long | USA |
VRTX Vertex Pharmaceuticals Incorporated | 676.13 k | 1.68 k shares | 5.19 | Common equity | Long | USA |
LLY Eli Lilly and Company | 605.25 k | 784.00 shares | 4.65 | Common equity | Long | USA |
Samsung Biologics Co Ltd
|
571.15 k | 886.00 shares | 4.39 | Common equity | Long | Korea, Republic of |
KRYS Krystal Biotech, Inc. | 544.86 k | 3.48 k shares | 4.18 | Common equity | Long | USA |
TMO Thermo Fisher Scientific Inc. | 534.28 k | 1.03 k shares | 4.10 | Common equity | Long | USA |
DHR Danaher Corporation | 530.03 k | 2.31 k shares | 4.07 | Common equity | Long | USA |
MEDP Medpace Holdings, Inc. | 518.94 k | 1.56 k shares | 3.98 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 515.73 k | 724.00 shares | 3.96 | Common equity | Long | USA |
UTHR United Therapeutics Corporation | 334.85 k | 949.00 shares | 2.57 | Common equity | Long | USA |
BNTX BioNTech SE | 328.52 k | 2.88 k shares | 2.52 | Common equity | Long | Germany |
CDNS Cadence Design Systems, Inc. | 327.20 k | 1.09 k shares | 2.51 | Common equity | Long | USA |
AstraZeneca PLC
|
325.63 k | 4.97 k shares | 2.50 | Common equity | Long | UK |
CTVA Corteva, Inc. | 316.93 k | 5.56 k shares | 2.43 | Common equity | Long | USA |
A Agilent Technologies, Inc. | 294.20 k | 2.19 k shares | 2.26 | Common equity | Long | USA |
INSM Insmed Incorporated | 283.62 k | 4.11 k shares | 2.18 | Common equity | Long | USA |
BRKR Bruker Corporation | 281.43 k | 4.80 k shares | 2.16 | Common equity | Long | USA |
QIAGEN NV
|
279.78 k | 6.28 k shares | 2.15 | Common equity | Long | Netherlands |
IONS Ionis Pharmaceuticals, Inc. | 269.19 k | 7.70 k shares | 2.07 | Common equity | Long | USA |
Sartorius AG | 267.41 k | 1.20 k shares | 2.05 | Preferred equity | Long | Germany |
CRL Charles River Laboratories International, Inc. | 263.42 k | 1.43 k shares | 2.02 | Common equity | Long | USA |
RVTY Revvity, Inc. | 258.38 k | 2.32 k shares | 1.98 | Common equity | Long | USA |
ALNY Alnylam Pharmaceuticals, Inc. | 240.25 k | 1.02 k shares | 1.84 | Common equity | Long | USA |
SRPT Sarepta Therapeutics, Inc. | 220.32 k | 1.81 k shares | 1.69 | Common equity | Long | USA |
EXAS Exact Sciences Corporation | 185.71 k | 3.31 k shares | 1.43 | Common equity | Long | USA |
TWST Twist Bioscience Corporation | 180.81 k | 3.89 k shares | 1.39 | Common equity | Long | USA |
RARE Ultragenyx Pharmaceutical Inc. | 177.66 k | 4.22 k shares | 1.36 | Common equity | Long | USA |
ICON PLC
|
170.70 k | 814.00 shares | 1.31 | Common equity | Long | Ireland |
Lonza Group AG
|
166.13 k | 281.00 shares | 1.28 | Common equity | Long | Switzerland |
LGND Ligand Pharmaceuticals Incorporated | 156.55 k | 1.46 k shares | 1.20 | Common equity | Long | USA |
LH Laboratory Corporation of America Holdings | 149.52 k | 652.00 shares | 1.15 | Common equity | Long | USA |
RGEN Repligen Corporation | 144.66 k | 1.00 k shares | 1.11 | Common equity | Long | USA |
AZTA Azenta, Inc. | 142.40 k | 2.85 k shares | 1.09 | Common equity | Long | USA |
BBIO BridgeBio Pharma, Inc. | 139.81 k | 5.10 k shares | 1.07 | Common equity | Long | USA |
NBIX Neurocrine Biosciences, Inc. | 139.50 k | 1.02 k shares | 1.07 | Common equity | Long | USA |
IQV IQVIA Holdings Inc. | 136.97 k | 697.00 shares | 1.05 | Common equity | Long | USA |
TECH Bio-Techne Corporation | 135.13 k | 1.88 k shares | 1.04 | Common equity | Long | USA |
RCKT Rocket Pharmaceuticals, Inc. | 129.12 k | 10.27 k shares | 0.99 | Common equity | Long | USA |
BEAM Beam Therapeutics Inc. | 126.41 k | 5.10 k shares | 0.97 | Common equity | Long | USA |
VYGR Voyager Therapeutics, Inc. | 113.66 k | 20.05 k shares | 0.87 | Common equity | Long | USA |
VCYT Veracyte, Inc. | 98.41 k | 2.49 k shares | 0.76 | Common equity | Long | USA |
RXRX Recursion Pharmaceuticals, Inc. | 85.01 k | 12.58 k shares | 0.65 | Common equity | Long | USA |
BIO Bio-Rad Laboratories, Inc. | 73.91 k | 225.00 shares | 0.57 | Common equity | Long | USA |
CDMO Avid Bioservices, Inc. | 71.41 k | 5.78 k shares | 0.55 | Common equity | Long | USA |
DVAX Dynavax Technologies Corporation | 69.58 k | 5.45 k shares | 0.53 | Common equity | Long | USA |
DOCS Doximity, Inc. | 64.92 k | 1.22 k shares | 0.50 | Common equity | Long | USA |
Tempus AI Inc
|
64.85 k | 1.92 k shares | 0.50 | Common equity | Long | USA |
AVTR Avantor, Inc. | 61.46 k | 2.92 k shares | 0.47 | Common equity | Long | USA |
CRISPR Therapeutics AG
|
54.00 k | 1.37 k shares | 0.41 | Common equity | Long | Switzerland |
NTLA Intellia Therapeutics, Inc. | 49.39 k | 4.24 k shares | 0.38 | Common equity | Long | USA |
BMY Bristol-Myers Squibb Company | 47.91 k | 847.00 shares | 0.37 | Common equity | Long | USA |
MRNA Moderna, Inc. | 41.62 k | 1.00 k shares | 0.32 | Common equity | Long | USA |
Bavarian Nordic A/S
|
39.18 k | 1.49 k shares | 0.30 | Common equity | Long | Denmark |
CRNX Crinetics Pharmaceuticals, Inc. | 30.47 k | 596.00 shares | 0.23 | Common equity | Long | USA |
BMRN BioMarin Pharmaceutical Inc. | 27.94 k | 425.00 shares | 0.21 | Common equity | Long | USA |
NGNE Neurogene Inc. | 25.79 k | 1.13 k shares | 0.20 | Common equity | Long | USA |
ARE Alexandria Real Estate Equities, Inc. | 18.44 k | 189.00 shares | 0.14 | Common equity | Long | USA |
SLP Simulations Plus, Inc. | 12.89 k | 462.00 shares | 0.10 | Common equity | Long | USA |
Evotec SE
|
11.57 k | 1.36 k shares | 0.09 | Common equity | Long | Germany |
FDMT 4D Molecular Therapeutics, Inc. | 9.73 k | 1.75 k shares | 0.07 | Common equity | Long | USA |
OABI OmniAb, Inc. | 0 | 240.00 shares | 0.00 | Common equity | Long | USA |
OABI OmniAb, Inc. | 0 | 240.00 shares | 0.00 | Common equity | Long | USA |